Dr. Jose Trevino is an Associate Professor of Surgery at the University of Florida College of Medicine. His clinical focus is on liver, bile duct and pancreas surgery.

Dr. Trevino earned his medical degree and completed his residency at the University of Illinois at Chicago. He was a research fellow at University of Texas M.D. Anderson Cancer Center in Houston and a clinical fellow in surgical oncology at H. Lee Moffitt Cancer Center and Research Institute in Tampa.

His research interests include pancreatic cancer biology, tumor signaling and chemoresistance. Dr. Trevino currently is investigating how pancreas cancer resists current chemotherapeutic strategies. He has discovered that exposure to nicotine, the addictive component of tobacco smoke, may contribute to pancreatic cancer resistance to chemotherapy by potentially increasing expression levels of certain oncoprotients, such as Src, a non-receptor tyrosine kinase and inhibitor of differentiation-1(Id-1), all of which have been demonstrated to contribute to pancreatic cancer tumor progression. This work, as well as other projects he is involved in, may lead to new treatment strategies against pancreatic cancer.

Dr. Trevino has earned various honors, including induction into the Alpha Omega Alpha Medical Honor Society and the American Association for Cancer Research Minority Scholar Award.